Gerlinger, Christoph

No ORCID on file · 10 papers in corpus · active 2020-2021

Study types

  • other 6
  • article 4

Condition tags

  • endometriosis 10
  • dysmenorrhea 2
article 2021
Additional file 1 of Patients’ and clinicians’ perspectives on item importance, scoring, and clinically meaningful differences for the Endometriosis Symptom Diary (ESD) and Endometriosis Impact Scale (EIS)
·doi:10.6084/m9.figshare.13535185.v1

Additional file 1. Examples of completed ranking tasks and material used for cognitive exploration tasks.

article 2021
Additional file 1 of Patients’ and clinicians’ perspectives on item importance, scoring, and clinically meaningful differences for the Endometriosis Symptom Diary (ESD) and Endometriosis Impact Scale (EIS)
·doi:10.6084/m9.figshare.13535185

Additional file 1. Examples of completed ranking tasks and material used for cognitive exploration tasks.

other 2021
Patient-reported utilization patterns of endometriosis medications in Europe: Real-world results from the non-interventional VIPOS study
·doi:10.25384/sage.c.5541987.v1

Introduction:Women with endometriosis require individualized, long-term treatment.Analyzing prescription choices, medication switches, discontinuations, and breaks can describe real-world treatment patterns and optimize pathways for women. …

other 2021
Patient-reported utilization patterns of endometriosis medications in Europe: Real-world results from the non-interventional VIPOS study
·doi:10.25384/sage.c.5541987

Introduction:Women with endometriosis require individualized, long-term treatment.Analyzing prescription choices, medication switches, discontinuations, and breaks can describe real-world treatment patterns and optimize pathways for women. …

other 2021
Patients’ and clinicians’ perspectives on item importance, scoring, and clinically meaningful differences for the Endometriosis Symptom Diary (ESD) and Endometriosis Impact Scale (EIS)
·doi:10.6084/m9.figshare.c.5259673

Abstract Background The Endometriosis Symptom Diary (ESD) and Endometriosis Impact Scale (EIS) are patient-reported outcome measures developed to evaluate efficacy in clinical trials and clinical practice. The ESD is a daily electronic diar…

other 2021
Patients’ and clinicians’ perspectives on item importance, scoring, and clinically meaningful differences for the Endometriosis Symptom Diary (ESD) and Endometriosis Impact Scale (EIS)
·doi:10.6084/m9.figshare.c.5259673.v1

Abstract Background The Endometriosis Symptom Diary (ESD) and Endometriosis Impact Scale (EIS) are patient-reported outcome measures developed to evaluate efficacy in clinical trials and clinical practice. The ESD is a daily electronic diar…

article 2021
sj-pdf-1-pev-10.1177_22840265211035993 – Supplemental material for Patient-reported utilization patterns of endometriosis medications in Europe: Real-world results from the non-interventional VIPOS study
·doi:10.25384/sage.15102132

Supplemental material, sj-pdf-1-pev-10.1177_22840265211035993 for Patient-reported utilization patterns of endometriosis medications in Europe: Real-world results from the non-interventional VIPOS study by Kerstin Becker, Klaas Heinemann, B…

article 2021
sj-pdf-1-pev-10.1177_22840265211035993 – Supplemental material for Patient-reported utilization patterns of endometriosis medications in Europe: Real-world results from the non-interventional VIPOS study
·doi:10.25384/sage.15102132.v1

Supplemental material, sj-pdf-1-pev-10.1177_22840265211035993 for Patient-reported utilization patterns of endometriosis medications in Europe: Real-world results from the non-interventional VIPOS study by Kerstin Becker, Klaas Heinemann, B…

other 2020
Safety of Dienogest and Other Hormonal Treatments for Endometriosis in Real-World Clinical Practice (VIPOS): A Large Noninterventional Study
·doi:10.6084/m9.figshare.12046359

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The …

other 2020
Safety of Dienogest and Other Hormonal Treatments for Endometriosis in Real-World Clinical Practice (VIPOS): A Large Noninterventional Study
·doi:10.6084/m9.figshare.12046359.v1

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The …